Andrew Nava's  Instablog

Andrew Nava
Send Message
Andrew Nava LLC is a healthcare focused consulting and investment firm. Prior to launching Andrew Nava LLC, I was a venture analyst, buy-side analyst, and most recently, the Director of Research at Actin Biomed, a New York-based healthcare investment firm where I was responsible for the medical,... More
My company:
Andrew Nava, LLC
  • Biotech Catalyst Watch for 2Q10 2 comments
    Apr 9, 2010 11:30 AM | about stocks: BCRX, APPY, AFFY, DCTH, SNTS

    Here's a short list of upcoming company milestones we're tracking at Andrew Nava, LLC:

    AspenBio Pharma (NASDAQ:APPY)

    APPY's AppyScore validation study completed enrollment March 23.  Final results are expected per management within 6-8 weeks of March 23, so approximately the week of May 3 up to including the week of May 17.  APPY's appendicitis diagnostic study was expanded from 600 to 800 patients after they withdrew their old 510K.

    Affymax (OTCPK:AFFY)

    AFFY and its partner Takeda are expecting top-line results from its pivotal registration study of Hematide in patients with chronic renal failure associated anemia.

    Delcath (NASDAQ:DCTH)

    DCTH is expecting data this month for its pivotal PHP Melphalan trial in patients with metastatic melanoma.  The primary endpoint is hepatic progression free survival.

    Santarus (NASDAQ:SNTS)

    SNTS is expecting data 2Q10 from its European study of Budesonide MMX in ulcerative colitis patients. Data from the US study is expected in 2H10.

    Biocryst Pharmaceuticals (NASDAQ:BCRX)

    BCRX is expecting top-line gout data from its BCX-4208 monotherapy trial.  Results are expected 2Q10.

    For more information on the above companies and trials, please visit andrewnava.com. We track over 300 public companies and have over 500 upcoming catalysts across 17 different catalyst types.



    Disclosure: No positions

    Stocks: BCRX, APPY, AFFY, DCTH, SNTS
Back To Andrew Nava's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (2)
Track new comments
  • Royboy1979
    , contributor
    Comments (5) | Send Message
     
    What are your thought on DCTH's upcoming data to be released this month? What (if anything) are you hearing that holds water? Thanks.
    9 Apr 2010, 10:21 PM Reply Like
  • Andrew Nava
    , contributor
    Comments (3) | Send Message
     
    Author’s reply » Royboy: Unfortunately, I can't comment on your question in a public forum. Please feel free to email me at anava@andrewnava.com. Thanks.
    10 Apr 2010, 11:52 AM Reply Like
Full index of posts »
Latest Followers

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.